Hyperprolactinaemia, drug-induced

PheWeb

E4_HYPERPRO_ADVERSE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital discharge: ATC codes for adverse effects of drugs ANY

Hospital Discharge: ICD-10 E22.1#

833

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10

132

Check minimum number of events None

132

Include endpoints None

132

E4_HYPERPRO_ADVERSE

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF5

Parent code in ICD-10 E22

Name in latin Hyperprolactinaemia

Similar endpoints

↥

List of similar endpoints to Hyperprolactinaemia, drug-induced based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	130	114	16
Unadjusted prevalence (%)	0.04	0.07	0.01
Mean age at first event (years)	39.30	37.37	53.07

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Hyperprolactinaemia, drug-induced
after Hyperprolactinaemia, drug-induced

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Hyperprolactinaemia, drug-induced

↥